Argenx
ARGX
#456
Rank
NZ$87.53 B
Marketcap
NZ$1,414
Share price
1.92%
Change (1 day)
21.04%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: NZ$87.53 Billion

As of February 2026 Argenx has a market cap of NZ$87.53 Billion. This makes Argenx the world's 456th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$87.53 B-3.66%
2025NZ$90.85 B36.82%
2024NZ$66.40 B86.09%
2023NZ$35.68 B8.1%
2022NZ$33.01 B22.61%
2021NZ$26.92 B38.55%
2020NZ$19.43 B90.27%
2019NZ$10.21 B95.39%
2018NZ$5.22 B85.16%
2017NZ$2.82 B
2014NZ$0.18 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Argenx was reported to be:

NZ$86.26 Billion
by Nasdaq info icon info icon
NZ$87.53 Billion
by CompaniesMarketCap info icon info icon